NEW TREATMENT OF CHRONIC PROSTATITIS: INTERFERON GAMMA
- Autores: Pushkar' D.Y.1, Kasyan G.R.1, Pushkar DY.1, Kasyan GR1
-
Afiliações:
- Edição: Nº 4 (2012)
- Páginas: 65-67
- Seção: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/279370
- ID: 279370
Citar
Texto integral
Resumo
The article presents the results from prospective open controlled study on efficacy and safety of the drug Ingaron (interferon gamma - IFN-γ) in 30 patients with chronic prostatitis (CP). Patients of the first group (n = 15) received standard therapy for CP (fluoroquinolone antibiotic and α-blocker) in combination with IFN-γ at a dose of 500 000 IU, patients of the control group (n = 15) - only standard therapy without the use of IFN. According to the results of study, of anti-relapse action of Ingaron persists for 6 months in 66.7% of patients of experimental group versus 20% of patients of control group after completion of treatment. Protracted treatment with Ingaron at the recommended dosage is safe and well tolerable, and can be recommended for the complex treatment of CP patients.
Palavras-chave
Bibliografia
- Глыбочко П.В., Попков В.М., Липский В.С. и др. Материалы Пленума правления Росс. Общества урологов. М., 2004. С. 40-1.
- Аполихин О.И., Сивков А.В., Ощепков В.Н. и др. Материалы Х Российского съезда урологов. М., 2002. С. 223-27.
- Зайцев А.В., Пушкарь Д.Ю. Безопасность и эффективность для инъекции лонгидазы 3000 МЕ у больных, страдающих интерстициальным циститом // Иммунология 2006. № 2. С. 121-34.
- Камалов А.А. Дорофеев С.Д. Современные взгляды на проблему хронического простатита // РМЖ 2004. № 7. С. 492-95.
- Пушкарь Д.Ю., Долгопятов Д.Г., Носовицкий П.Б., Эль-Мазбух А.М. Материалы Пленума РОУ. Саратов, 2004. 55 с.
- Пушкарь Д.Ю., Сегал А.С., Юдовский С.О. Противомикробная терапия хронического неспецифического простатита // Consilium Medicum 2002. Т. 4. № 5. С. 249-51.
- Nickel JC. Prostatitis: lessons from the 20th century. BJU Int 2000;85:179-85.
- Nickel JC. Treatment of chronic prostatitis/chronic pelvic pain syndrome. Int J Antimicrob Agents 2008;31(1):112-16.
- El-Sakka, et al. Lower urinary tract symptoms in patients with erectile dysfunction: Analysis of risk factors. J Sex Med 2006;3:144-49.
- Krieger, JN, Egan KJ, Ross SO, et al. Chronic pelvic pains represent the most prominent urogenital symptoms of "chronic prostatitis". Urology 1996;48:715-21.
- Rosen R, Altwein J, Boyle P, Kirby, et al. Lower urinary tract symptoms and male sexual dysfunction: The multinational survey of the aging male (MSAM-7). Eur Urol 2003;44:637-49.
- Vallancien G, Emberton M, Harving N, van Moorselaar RJ. for the ALF-One Study Group. Sexual dysfunction in 1,274 European men suffering from lower urinary tract symptoms. J Urol 2003;169:2257-61.
Arquivos suplementares
